Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

This publication has 29 references indexed in Scilit:

• Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates
  Proceedings of the National Academy of Sciences, 2009
• Structure and genetics ofShigellaO antigens
  FEMS Microbiology Reviews, 2008
• Laboratory-Confirmed Shigellosis in the United States, 1989-2002: Epidemiologic Trends and Patterns
  Clinical Infectious Diseases, 2004
• The Efficacy of aSalmonella typhiVi Conjugate Vaccine in Two-to-Five-Year-Old Children
  New England Journal of Medicine, 2001
• Safety and Immunogenicity ofShigella sonneiandShigella flexneri2a O‐Specific Polysaccharide Conjugates in Children
  The Journal of Infectious Diseases, 1999
• Shigella lipopolysaccharide antibodies in pediatric populations
  The Pediatric Infectious Disease Journal, 1995
• Perspective: Hypothesis: Serum IgG Antibody Is Sufficient to Confer Protection against Infectious Diseases by Inactivating the Inoculum
  The Journal of Infectious Diseases, 1995
• Hypothesis for Vaccine Development: Protective Immunity to Enteric Diseases Caused by Nontyphoidal Salmonellae and Shigellae May Be Conferred by Serum IgG Antibodies to the O-Specific Polysaccharide of Their Lipopolysaccharides
  Clinical Infectious Diseases, 1992
• HUMAN IMMUNITY TO THE MENINGOCOCCUS
  The Journal of Experimental Medicine, 1969
• The Trend of Prevention, Therapy and Epidemiology of Dysentery since the Discovery of Its Causative Organism
  New England Journal of Medicine, 1936